Why Chinese companies are eyeing SGX again

Why Chinese companies are eyeing SGX again

According to statistics, there are still around 100 Chinese companies listed on SGX today CONNECTIVITY between the capital markets of Singapore and China has continued to deepen, with cooperation strengthening and interest among Chinese companies in secondary listings in Singapore gradually rising. Market participants noted that Chinese businesses now have clearer listing objectives and are…

Read More

After EVs, smart driving tech to power China’s auto exports

After EVs, smart driving tech to power China’s auto exports

China exported a record 7.1 million cars in 2025, buoyed by growing demand for new-energy vehicles (NEVs) as the global shift toward electrification gathered pace, allowing the country to keep its position as the world’s largest auto exporter. As NEVs become more widespread, industry insiders and analysts are pointing to autonomous driving as the next…

Read More

Peloton cuts 11% of jobs, with engineering teams getting hit

Peloton cuts 11% of jobs, with engineering teams getting hit

The fitness technology company joins a slew of other tech companies that have recently slashed their workforces Published Sat, Jan 31, 2026 · 11:32 AM [LONDON] Peloton Interactive, the long-struggling fitness technology company, slashed 11 per cent of its workforce in a cost-cutting move, according to a source with knowledge of the matter. Peter Stern,…

Read More

Coliwoo to acquire S$101 million Changi asset from ESR-Reit

Coliwoo to acquire S1 million Changi asset from ESR-Reit

The property’s location in Changi Business Park provides access to an established corporate tenant base [SINGAPORE] Co-living operator Coliwoo has inked a deal to acquire a hotel property from ESR-Real Estate Investment Trust (Reit) for about S$101 million. The deal, announced on Friday (Jan 30) through a bourse filing, involves the hotel strata lot located…

Read More

AstraZeneca strikes deal for up to US$18.5 billion to license weight-loss drugs from China’s CSPC

AstraZeneca strikes deal for up to US.5 billion to license weight-loss drugs from China’s CSPC

The deal builds on existing collaboration between the companies in areas such as artificial intelligence Published Fri, Jan 30, 2026 · 08:50 PM [SHANGHAI] AstraZeneca will license experimental drugs for obesity and weight-related conditions from CSPC Pharmaceutical Group and collaborate on other projects, paying US$1.2 billion upfront and up to US$17.3 billion more if milestones…

Read More

STI tracks overnight Wall Street declines as it slides 0.5%

STI tracks overnight Wall Street declines as it slides 0.5%

Across the broader market, decliners beat gainers 365 to 228, with 1.6 billion securities worth about S$2.1 billion changing hands [SINGAPORE] Singapore’s Straits Times Index (STI) dropped on Friday (Jan 30) after major US indices S&P 500 and Nasdaq Composite Index slid overnight. The STI slid 0.5 per cent or 24.9 points to 4,905.13, with…

Read More